BRAINED Study
Start date:April 2018 End date:
August 2020 Co-ordinated by:
Neurosurgery Department, Western General Hospital, Edinburgh Main trial site:
RIE & Western General Hospital, Edinburgh
Blood samples will be assessed using infrared spectroscopy as part of a project looking at tumour biomarkers to ascertain whether people most at risk of having a brain tumour can be correctly identified.
This is a tissue governance project aiming to recruit 600 participants in order to inform a larger trial.
Chief Investigator
Mr Paul Brennan
Consultant Neurosurgeon
Local PI
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
Research Team
Rachel O'Brien
Lead Research Nurse
Clare Moceivei
Research Nurse- Bank Staff
Allan MacRaild
Stroke Lead Research Nurse
Jessica Teasdale
Senior Research Nurse - Stroke/Neurosurgery
Michelle Curtin
Senior Research Nurse - Stroke/Neurosurgery
More EMERGE Trials
TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.
TARGET-CTCA Trial
Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.
IONA Study
Identification of Novel Psychoactive Substances (IONA)
ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study
ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)